CD86 and neoplasm: Consistent with the transcriptome changes, corresponding alterations in the immune cell populations towards an adaptive anti-tumor immune response within the intratumoral compartments were also demonstrated including an increase in CD8+ T cells coupled with CD86+ activated Mo-MDSCs and TAMs, ultimately leading to an anti-tumor immune response.